このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Optimizing Elderly Hearing Loss Care in Hong Kong A Cost-Effectiveness and Satisfactory Analysis of a Pilot Collaborative Model Between Otorhinolaryngologists and Family Medicine Specialists

2026年8月21日 更新者:YEUNG WING CHI ZENON、Tseung Kwan O Hospital, Hong Kong

This study will evaluate a new collaborative elderly hearing-loss service in Hong Kong. The service is based in Family Medicine (FM) and supported by Ear, Nose and Throat (ENT) specialist nurses and audiology services. It aims to provide earlier hearing assessment, counselling, hearing-aid referral or fitting where appropriate, and referral to ENT specialists when more complex ear problems are suspected.

The study will compare this new service with the existing ENT elderly hearing clinic. About 500 adults aged 65 years or above with progressive hearing loss will be enrolled. Researchers will compare the time to hearing assessment and hearing-related abilities and quality of life score, satisfactory score related to the care in the FM and ENT cohort, compliance to hearing aids, and referral to ENT services. The findings may help determine whether the new service is safe, cost-effective and improves access to hearing care.

調査の概要

状態

まだ募集していません

詳細な説明

Age-related hearing loss is common and can affect communication, daily activities, social participation, emotional wellbeing, and quality of life. Older adults with hearing loss may experience delays in accessing assessment and rehabilitation because demand for ENT specialist outpatient services is exceedingly high. A collaborative care pathway based in Family Medicine may allow suitable patients to receive earlier hearing assessment and rehabilitation while maintaining clear routes for referral to ENT when clinically indicated.

This prospective, parallel-cohort observational study will evaluate a new FM elderly hearing clinic at Tseung Kwan O South Family Medicine Clinic. The clinic is delivered by Family Medicine doctors with support from ENT specialist nurses and audiology services. It will be compared with the established ENT elderly hearing clinic at ENT Specialist Outpatient Clinic at Tseung Kwan O Hospital. Allocation will follow usual clinical referral, triage, and service pathways; participants will not be randomized.

Consecutive eligible patients aged 65 years or above with bilateral progressive hearing loss, earwax impaction, or a referral need for hearing aids will be invited to participate. Patients with urgent or complex otologic presentations requiring specialist care, including sudden sensorineural hearing loss, acute ear infection or otorrhoea, tympanic-membrane perforation, or suspected cholesteatoma or other serious middle-ear disease, will be excluded. Patients must be able to provide informed consent, either independently or with sufficient caregiver support to complete study questionnaires.

Approximately 500 participants will be recruited over about 12 months: approximately 100 in the FM cohort and 400 in the ENT cohort. Participants will undergo hearing assessment, including pure-tone audiometry or an equivalent assessment, and will receive care according to their assigned usual-care pathway. In the FM pathway, clinicians will assess hearing loss, provide counselling, arrange audiologic testing, facilitate hearing-aid fitting where indicated, and refer patients to ENT according to predefined escalation criteria. In the ENT pathway, participants will receive assessment and treatment through established specialist clinic and audiology protocols.

Baseline data will include demographic and clinical information, comorbidities, presenting symptoms, otologic findings, and hearing-test results. Participants will complete the traditional Chinese versions of Speech, Spatial and Qualities of Hearing Scale-12 (SSQ-12), the Older People's Quality of Life Brief questionnaire (OPQOL-Brief), the 15-item Geriatric Depression Scale (GDS-15), and a structured patient-satisfaction questionnaire. These measures will be repeated after hearing-aid fitting, where applicable, to assess changes in hearing-related function, quality of life, mood, experience of care, hearing-aid use, and adherence. Participants with a GDS-15 score of 8 or higher will be provided with information regarding mood disturbance and referred to Family Medicine for further assessment and management of possible depression.

The study will compare time from first presentation with hearing loss to first hearing assessment and, where indicated, to hearing-aid prescription. It will also compare patient-reported outcomes, satisfaction, hearing-aid compliance, clinic consultation time, and the proportion of FM-pathway patients subsequently referred to ENT. Researchers will assess changes in the volume and pattern of ENT referrals for elderly hearing loss after implementation of the FM clinic. Analyses will include an overall comparison between the FM and ENT cohorts, as well as a secondary matched comparison between the FM cohort and a similar-sized ENT subgroup with comparable age, baseline characteristics, and hearing-loss severity.

The cost-effectiveness analysis will consider the number of clinic visits before discharge, proportion of patients that require referral to ENT specialist outpatient clinic. The study is intended to assess whether this collaborative model can provide safe, satisfactory, and timely hearing rehabilitation for older adults while reducing avoidable demand on specialist ENT outpatient services.

研究の種類

観察的

入学 (推定)

500

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Zenon YEUNG, MbChB (CUHK), FRCS (Edin)
  • 電話番号:852-39493549
  • メール:zenon.yeung@ha.org.hk

研究連絡先のバックアップ

  • 名前:Thomas SC Hui, BSc
  • 電話番号:+852-39493549
  • メール:hsc526@ha.org.hk

研究場所

      • Hong Kong、香港
        • Department of Ear, Nose and Throat at United Christian Hospital and Tseung Kwan O Hospital
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 高齢者

健康ボランティアの受け入れ

いいえ

サンプリング方法

非確率サンプル

調査対象母集団

The study population comprises adults aged 65 years or above presenting with hearing loss to either the new Family Medicine elderly hearing clinic at Tseung Kwan O South Family Medicine Clinic or the existing ENT elderly hearing clinic at specialist outpatient clinic at Tseung Kwan O Hospital, Hong Kong. Participants will have progressive bilateral hearing loss, hearing difficulty associated with earwax impaction, or a need for hearing-aid assessment or rehabilitation.

Approximately 500 participants will be recruited: approximately 100 participants in the Family Medicine clinic cohort and 400 participants in the ENT clinic cohort. The study excludes patients with urgent or complex otologic conditions that require prompt specialist ENT evaluation.

説明

Inclusion Criteria:

  • Aged 65 years or above.
  • Attending the Family Medicine elderly hearing clinic at Tseung Kwan O South Family Medicine Clinic or the ENT elderly hearing clinic at Specialist Outpatient Clinic at Tseung Kwan O Hospital.
  • Bilateral progressive hearing loss for more than 1 month without acute ear infection; or earwax impaction affecting hearing; or referred for hearing-aid assessment, prescription, fitting, or follow-up.
  • Able to provide written informed consent independently, or with caregiver support sufficient to facilitate completion of study questionnaires.
  • Adequate language proficiency, including Cantonese where applicable, to complete the validated study questionnaires.

Exclusion Criteria:

  • Sudden sensorineural hearing loss.
  • Acute otitis, otorrhoea, or other acute ear infection requiring urgent assessment.
  • Tympanic-membrane perforation.
  • Suspected cholesteatoma or other serious middle-ear disease.
  • Other red-flag otologic presentations requiring urgent ENT specialist evaluation.
  • Severe cognitive impairment that, in the clinician's judgement, prevents meaningful informed consent or completion of study questionnaires.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
Family Medicine Elderly Hearing Clinic Cohort
Older adults with hearing loss managed through the Family Medicine elderly hearing clinic at Tseung Kwan O South Family Medicine Clinic. Care is provided by Family Medicine doctors with support from ENT specialist nurses and audiology services, with referral to ENT according to predefined clinical escalation criteria.
ENT Elderly Hearing Clinic Cohort
Older adults with hearing loss managed through the existing ENT elderly hearing clinic at the Specialist Outpatient Clinic at Tseung Kwan O Hospital, with assessment and treatment delivered according to established specialist-clinic and audiology protocols.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in hearing-related function measured by the Speech, Spatial and Qualities of Hearing Scale-12 (SSQ-12)
時間枠:Baseline to post-hearing aid fitting review, up to 24 months
Change in SSQ-12 score from baseline to follow-up. The SSQ-12 is a 12-item patient-reported measure of hearing abilities and hearing quality; higher scores indicate better self-reported hearing ability.
Baseline to post-hearing aid fitting review, up to 24 months
Change in quality of life measured by the Older People's Quality of Life Brief questionnaire (OPQOL-Brief)
時間枠:Baseline to post-hearing aid fitting review, up to 24 months
Change in OPQOL-Brief score from baseline to follow-up. The OPQOL-Brief is a 13-item patient-reported measure of quality of life in older adults; higher scores indicate better quality of life.
Baseline to post-hearing aid fitting review, up to 24 months
Change in depressive symptoms measured by the 15-item Geriatric Depression Scale (GDS-15)
時間枠:Baseline to post-hearing aid fitting review, up to 24 months
Change in GDS-15 score from baseline to follow-up. The GDS-15 is a 15-item self-report screening measure of depressive symptoms in older adults; total scores range from 0 to 15, with higher scores indicating more depressive symptoms.
Baseline to post-hearing aid fitting review, up to 24 months
Patient satisfaction with the hearing-care pathway
時間枠:Baseline to post-hearing aid fitting review, up to 24 months
Patient satisfaction score measured using the study structured satisfaction questionnaire at follow-up. Higher scores indicate greater satisfaction with the hearing-care service received.
Baseline to post-hearing aid fitting review, up to 24 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Time from first presentation with hearing loss to first hearing assessment and hearing rehabilitation
時間枠:Up to 12 months
Number of days from the first submission of referral for hearing loss to completion of the first hearing assessment and hearing rehabilitation, derived from Hospital Authority electronic clinical records.
Up to 12 months
Referral from the Family Medicine pathway to ENT specialist outpatient care
時間枠:Up to 24 months
Proportion of participants in the Family Medicine elderly hearing clinic cohort who are referred to ENT specialist outpatient care, together with documented reasons for referral or pathway escalation.
Up to 24 months
Hearing-aid use and adherence
時間枠:At follow-up, up to 1 year after hearing aid fitting
Proportion of participants prescribed or fitted with hearing aids who report hearing-aid use, adherence, perceived benefit, or problems at follow-up.
At follow-up, up to 1 year after hearing aid fitting

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Zenon Yeung, MbChB (CUHK), FRCS (Edin)、Department of Ear, Nose and Throat, Tseung Kwan O Hospital

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2027年8月1日

研究の完了 (推定)

2028年8月1日

試験登録日

最初に提出

2026年8月12日

QC基準を満たした最初の提出物

2026年8月21日

最初の投稿 (実際)

2026年8月24日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月24日

QC基準を満たした最後の更新が送信されました

2026年8月21日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する